These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 412560)

  • 1. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
    Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD
    Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of brain serotonin in the treatment of myoclonus.
    Chadwick D; Jenner P; Harris R; Reynolds EH; Marsden CD
    Lancet; 1975 Sep; 2(7932):434-5. PubMed ID: 51240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
    Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
    N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH; Sethy VH
    Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of serotonin precursors in postanoxic action myoclonus.
    De Léan J; Richardson JC; Hornykiewicz O
    Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam.
    Carroll WM; Walsh PJ
    Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292
    [No Abstract]   [Full Text] [Related]  

  • 7. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor.
    Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B
    Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Palatal myoclonus associated with a decrease in 5-hydroxy-indole acetic acid in cerebrospinal fluid and responding to clonazepam].
    Gauthier S; Young SN; Baxter DW
    Can J Neurol Sci; 1981 Feb; 8(1):51-4. PubMed ID: 6164459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Treatment of post-anoxic intention myoclonus.
    Van Woert MH; Sethy VH
    Lancet; 1974 Jun; 1(7869):1285. PubMed ID: 4134164
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder.
    Chadwick D; Hallett M; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():183-90. PubMed ID: 2418645
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemistry and therapeutics of posthypoxic myoclonus.
    Van Woert MH; Rosenbaum D; Chung EY
    Adv Neurol; 1986; 43():171-81. PubMed ID: 2418644
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L; Sharpless N; Wolfson L; Engel J; Katzman R
    Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity.
    Giménez-Roldán S; Mateo D; Muradas V; De Yebenes JG
    Clin Neuropharmacol; 1988 Apr; 11(2):151-60. PubMed ID: 2454156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin and myoclonus.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
    Guilleminault C; Tharp BR; Cousin D
    J Neurol Sci; 1973 Apr; 18(4):435-41. PubMed ID: 4540626
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT.
    Jenner P; Pratt JA; Marsden CD
    Adv Neurol; 1986; 43():629-43. PubMed ID: 2418652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttraumatic intention myoclonus.
    Starosta-Rubinstein S; Bjork RJ; Snyder BD; Tulloch JW
    Surg Neurol; 1983 Aug; 20(2):131-2. PubMed ID: 6603671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-5HTP and drugs acting on serotonin metabolism in various myoclonic syndromes.
    Avanzini G; Bossi L; Caraceni T; Consolazione A; Franceschetti S; Negri S; Parati E
    Monogr Neural Sci; 1980; 5():142-52. PubMed ID: 6976509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa.
    Ramaekers VT; Senderek J; Häusler M; Häring M; Abeling N; Zerres K; Bergmann C; Heimann G; Blau N
    Mol Genet Metab; 2001 Jun; 73(2):179-87. PubMed ID: 11386854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-tryptophan-carbidopa trial in patients with long-standing progressive myoclonus epilepsy.
    Leino E; MacDonald E; Airaksinen MM; Riekkinen PJ; Salo H
    Acta Neurol Scand; 1981 Aug; 64(2):132-41. PubMed ID: 6172951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.